Cvs Health Corp Stock Price, News & Analysis

Aetna, a CVS Health company, has been recommended by the State of Michigan for a new contract to serve MI Coordinated Health beneficiaries eligible for both Medicare and Medicaid. The contract will provide a Highly Integrated Dual Eligible Special Needs Plan (HIDE SNP), offering Medicare benefits, most Medicaid covered benefits, and integrated long-term services and supports.

Aetna will continue serving 10 counties and expand to 29 additional counties in 2027. The company has been serving dually eligible beneficiaries in Michigan for over 10 years, currently managing health benefits for about 8,500 members. The new contract is expected to begin on January 1, 2026, and end on December 31, 2033, with renewal options.

Aetna, a CVS Health company, announced that 88% of its Medicare Advantage members are in 2025 Medicare Advantage Prescription Drug (MAPD) plans rated 4 stars or higher by CMS. Notably, 68% of members are in 4.5-star plans. The company achieved its highest-ever member experience score since the Quality Bonus Stars Program began in 2012.

Key highlights include:

• Aetna National Group PPO (H5522) with 1.4 million members maintained 4.5 stars for the 13th consecutive year
• Aetna National Individual PPO (H5521) with 1.1 million members improved to 4.5 stars
• Aetna Pennsylvania HMO (H3959) with 235K members earned 4.5 stars with near-perfect performance in Member Experience
• Aetna Florida HMO (H1609) with 155K members earned 4 stars

Aetna achieved 4+ star performance across all four key domains measured by CMS and excelled in various individual Star measures.

CVS Health (NYSE: CVS) is preparing for Hurricane Milton's expected landfall in Florida. The company is focusing on ensuring the safety and health of its customers, members, and employees while providing access to essential products and services. Key actions include:

• CVS Pharmacy is reminding patients to refill prescriptions and stocking up on emergency supplies.
• CVS Caremark is enabling emergency prescription refills in affected areas.
• CVS Specialty is arranging alternate delivery for patients in the emergency zone.
• Aetna is expanding support for Medicare and Commercial members and offering mental health resources.
• Employee safety checks and support services are being implemented.

CVS Health advises following evacuation orders, safeguarding current medications, and maintaining written records of prescriptions. The company is coordinating with disaster relief organizations to support community response and recovery efforts.

CVS Health (NYSE: CVS) has announced that it will hold a conference call with analysts and investors on Wednesday, November 6th, 2024, at 8:00 a.m. ET to discuss its third quarter 2024 financial results. The company will also broadcast an audio webcast of the event simultaneously on the Investor Relations section of its website at investors.cvshealth.com. The webcast will be archived on the site for one year following the event, allowing interested parties to access the information at a later date.

FARE (Food Allergy Research & Education) is partnering with CVS Pharmacy for the third consecutive year on the Teal Pumpkin Project, a movement creating a more inclusive Halloween for those with food allergies. CVS Pharmacy is expanding its Teal Pumpkin Project line, offering over 60 non-food goodies in more than 9,000 stores nationwide and on CVS.com.

The partnership aims to address the challenges faced by children with food allergies during Halloween, as over 65% have reported negative experiences due to their condition. CVS's expanded selection includes trick-or-treat buckets, light-up bracelets, glow sticks, pumpkin flashlights, and new bulk items like prefilled mini-teal pumpkins.

Families, schools, and community event organizers can find participating CVS store locations on FARE's interactive neighborhood map and mark their addresses as providing non-food treats for Halloween.

Aetna, a CVS Health company, has announced its 2025 Medicare products, focusing on core benefits that support overall health. The plans offer value, choice, and affordability with options including:

- $0 monthly plan premium
- $0 primary care copay
- $0 copay for Tier 1 drugs
- Dental, vision, hearing, and SilverSneakers benefits in every county served

Aetna will offer Medicare Advantage Prescription Drug (MAPD) plans in 44 states plus Washington, D.C., expanding to 76 new counties. The company estimates that 83% of Medicare-eligible beneficiaries will have access to a $0 monthly premium Aetna MA plan. New offerings include Chronic Condition Special Needs Plans (C-SNPs) in select areas and expanded Dual Eligible Special Needs Plans (D-SNPs).

The plans are backed by CVS Health's resources, offering access to MinuteClinic locations, OTC benefits, and Healthy Home Visits through Signify Health.

CVS Health (NYSE: CVS) is preparing for Hurricane Helene's landfall in Florida. The company is taking steps to ensure customers, patients, members, and colleagues have access to necessary products and services. Key actions include:

- CVS Pharmacy reaching out to patients for prescription refills
- Stocking additional emergency supplies in stores
- CVS Caremark enabling one-time emergency refills
- CVS Specialty contacting patients about alternate delivery arrangements
- Aetna expanding engagement with Medicare and Commercial members
- Liberalizing Resources For Living services for mental health support

CVS Health is also supporting employees at risk from the storm and providing community resources. The company offers tips for managing prescriptions during evacuations and emphasizes following local evacuation orders.

CVS Health (NYSE: CVS) has declared a quarterly dividend of $0.665 per share on its Common Stock. The dividend will be paid on November 1, 2024, to shareholders of record as of October 21, 2024. This announcement demonstrates CVS Health's commitment to returning value to its shareholders through consistent dividend payments. The quarterly dividend rate remains unchanged from previous distributions, indicating stability in the company's dividend policy. This news is particularly relevant for income-focused investors and those monitoring CVS Health's financial health and shareholder returns.

CVS Health (NYSE: CVS) has announced that CVS Pharmacy locations in Massachusetts are now offering hormonal contraceptive prescribing services. This initiative aims to address the issue of contraceptive deserts and improve access to birth control. Patients aged 18 and older can visit any Massachusetts CVS Pharmacy for a consultation, which includes a health screening and blood pressure check. If eligible, pharmacists can prescribe various types of hormonal contraception.

The service costs $39 for the consultation, regardless of whether medication is prescribed. This new offering is part of a broader effort to increase access to reproductive health care and follows similar services already available in several other states. The move is supported by Massachusetts legislators and is seen as a step towards addressing disparities in contraceptive access.